Alpha Cognition (ACOG) director awarded shares and stock options
Rhea-AI Filing Summary
Alpha Cognition Inc. director Phillip Joseph Mertz reported new equity awards dated January 14, 2026. He received 7,241 common shares at a price of $0, described as restricted stock units that vest one year from the grant date. He was also granted 8,437 common share options with an exercise price of $6.56, which will vest one year from grant and expire on January 14, 2036.
Following these awards, Mertz directly holds 29,703 common shares and 8,437 options. An additional 12,560 common shares are held indirectly by Mertz Holdings, and he disclaims beneficial ownership of those securities except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did Alpha Cognition (ACOG) report for Phillip Joseph Mertz?
The filing reports that director Phillip Joseph Mertz received new equity awards on January 14, 2026, including common shares and stock options in Alpha Cognition Inc..
How many Alpha Cognition (ACOG) shares did the director receive in this Form 4?
Mertz received 7,241 common shares at a price of $0, characterized as restricted stock units that vest one year from the date of grant.
What stock options were granted to the Alpha Cognition (ACOG) director?
He was granted 8,437 common share options with an exercise price of $6.56 per share. These options vest one year from the grant date and expire on January 14, 2036.
What is Phillip Joseph Mertz’s direct share ownership in Alpha Cognition (ACOG) after the transaction?
After the reported transaction, Mertz directly owns 29,703 common shares of Alpha Cognition Inc., along with 8,437 stock options.
What indirect Alpha Cognition (ACOG) holdings are reported for Mertz?
The filing shows 12,560 common shares held indirectly by Mertz Holdings. Mertz disclaims beneficial ownership of these securities except to the extent of his pecuniary interest.
When do the Alpha Cognition (ACOG) restricted stock units and options granted to Mertz vest?
The restricted stock units represented by the 7,241 common shares and the 8,437 stock options each vest one year from the date of grant, which is January 14, 2026.